Stoykova et al. suggested that targeting critical metabolic enzymes of PCa lipid uptake, synthesis, and oxidation processes demonstrated anti-PCa effects 79; for example, the FASN inhibitor IPI-9119 improves cancer metabolomics and induces PCa apoptosis, potentially providing a novel approach for preventing and treating metastatic PCa 52. The gene discussed is FASN; the disease is cancer.